Internuclear opthalmoplegia: Difference between revisions
(Text replacement - "* " to "*") |
|||
| Line 2: | Line 2: | ||
[[File:Ino v2.png|thumbnail|Internuclear opthalmoplegia, courtesy of sketchy medicine]] | [[File:Ino v2.png|thumbnail|Internuclear opthalmoplegia, courtesy of sketchy medicine]] | ||
* | *Disruption of conjugate gaze. | ||
*Results in [[diplopia]] when looking contralateral (to affected eye). | |||
*Results in [[diplopia]] when looking contralateral (to affected eye) | *Localized to Midbrain or Pons. | ||
* | *Paramedian Pontine Reticular Formation (PPRF) is the conjugate gaze center for horizontal eye movements. Innervates ipsilateral Abducens (CN VI) nucleus. Abducens nucleus signals ipsilateral lateral rectus to contract and sends a second via MLF to contralateral oculomotor (CN III) nucleus, causing contraction on the contralateral medial rectus. | ||
*Lesions in the Medial Longitudinal Fasiculus (MLF) result in intranuclear ophthalmoplegia (INO). | |||
*Associated with one and one-half syndrome (lesion involving the PPRF and ipsilateral MLF) | |||
==Clinical Features== | ==Clinical Features== | ||
*Weakness in adduction of affected eye with limitation in horizontal gaze. | |||
*May result in horizontal diplopia | |||
*Horizontal nystagmus in unaffected eye | |||
*Convergence remains intact (differentiates CN III palsy from INO) | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Multiple Sclerosis (often presents with bilateral internuclear ophthalmoplegia) | |||
*Cerebrovascular disease | |||
*Malignancy located in brainstem and 4th ventricle | |||
*CN III palsy | |||
==Evaluation== | ==Evaluation== | ||
*Neurologic exam | |||
*The use of optokinetic tape is highly sensitive for testing for INO | |||
*MRI | |||
==Management== | ==Management== | ||
*Symtoms will often resolve on their own. Patients with cerebrovascular disease are less likely to have recovery. | |||
*Patching of eye can aid in relief of diplopia | |||
*Diframpadine, potassium channel blocker, has been used in patients with demyelinating disease | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Ropper A, Klein J, Samuels M. Adams and Victor's Principles of Neurology 10th Edition. McGraw-Hill Education / Medical; 2014. | |||
<references/> | |||
Serra A, Skelly MM, Jacobs JB, et al. Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine. Neurology 2014; 83:192. | |||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Symptoms]] | [[Category:Symptoms]] | ||
Revision as of 05:09, 4 August 2017
Background
- Disruption of conjugate gaze.
- Results in diplopia when looking contralateral (to affected eye).
- Localized to Midbrain or Pons.
- Paramedian Pontine Reticular Formation (PPRF) is the conjugate gaze center for horizontal eye movements. Innervates ipsilateral Abducens (CN VI) nucleus. Abducens nucleus signals ipsilateral lateral rectus to contract and sends a second via MLF to contralateral oculomotor (CN III) nucleus, causing contraction on the contralateral medial rectus.
- Lesions in the Medial Longitudinal Fasiculus (MLF) result in intranuclear ophthalmoplegia (INO).
- Associated with one and one-half syndrome (lesion involving the PPRF and ipsilateral MLF)
Clinical Features
- Weakness in adduction of affected eye with limitation in horizontal gaze.
- May result in horizontal diplopia
- Horizontal nystagmus in unaffected eye
- Convergence remains intact (differentiates CN III palsy from INO)
Differential Diagnosis
- Multiple Sclerosis (often presents with bilateral internuclear ophthalmoplegia)
- Cerebrovascular disease
- Malignancy located in brainstem and 4th ventricle
- CN III palsy
Evaluation
- Neurologic exam
- The use of optokinetic tape is highly sensitive for testing for INO
- MRI
Management
- Symtoms will often resolve on their own. Patients with cerebrovascular disease are less likely to have recovery.
- Patching of eye can aid in relief of diplopia
- Diframpadine, potassium channel blocker, has been used in patients with demyelinating disease
References
Ropper A, Klein J, Samuels M. Adams and Victor's Principles of Neurology 10th Edition. McGraw-Hill Education / Medical; 2014.
Serra A, Skelly MM, Jacobs JB, et al. Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine. Neurology 2014; 83:192.
